Watch for the New Oral GLP-1 Agonist Orforglipron

May 2026

More patients will be taking ORAL GLP-1 agonists now that orforglipron (Foundayo) is approved for overweight or obesity in adults.

It’s another daily, oral option...like oral semaglutide (Wegovy).

But orforglipron can be taken with or without food. Oral semaglutide must be taken with a max of 4 oz of water at least 30 minutes before the first food, other beverage, or oral meds of the day.

Practical advice for a better career, with unlimited access to CE

Hospital Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Sepsis Help Implement Updated Sepsis Guidelines to Improve Outcomes
Allergic Reactions Gather Details if Patients Report a Local Anesthetic Allergy
Med Safety Be Prepared When Patients Need Reversal Meds or Antidotes
Seizures Keep Safety in Mind With Long-Term Antiseizure Meds
GLP-1 Agonists Watch for the New Oral GLP-1 Agonist Orforglipron
Pain Brush Up on Non-Opioid Pain Medications
Migraine Know Which Meds Are Used for Acute Migraine in the ED
Rumor vs Truth Listen for Questions About Gabapentin

Watch for the New Oral GLP-1 Agonist Orforglipron

Practical advice for a better career, with unlimited access to CE

Table of Contents